AACR-NCI-EORTC International Conference on
Molecular Targets and Cancer Therapeutics
October 19-23, 2013
Hynes Convention Center
Boston, MA, USA
Abstract submission deadline: Monday, August 12
Early registration deadline: Friday, August 9
SCIENTIFIC COMMITTEE CO-CHAIRPERSONS:
Jeffrey A. Engelman, Massachusetts General Hospital, Charlestown, MA, USA (AACR)
Lee J. Helman, National Cancer Institute, Bethesda, MD, USA (NCI)
Sabine Tejpar, Catholic University of Leuven, Leuven, Belgium (EORTC)
Housing, registration, and abstract submission will open in mid-June.
Hosted by the American Association for Cancer Research, the National Cancer Institute, and the European Organisation for Research and Treatment of Cancer, the 2013 Molecular Targets and Cancer Therapeutics conference will bring together an estimated 3,000 academics, scientists, and pharmaceutical industry representatives from across the globe to discuss innovations in drug development, target selection, and the impact of new discoveries in molecular biology.
During the last few years, numerous innovative agents have been discovered as a result of tremendous developments in the understanding of the molecular basis of cancer. Further clinical progress in cancer treatment will be accomplished mainly through the conduct of translational research projects, efficient new drug development and the execution of large, prospective, randomized, multicentre cancer clinical trials. This requires a joint and global approach, and early and optimal exchange of information.
Continuing Medical Education Activity AMA PRA Category 1 CreditsTM available